Index by author
February 01, 1995; Volume 23,Issue 2
A
Abadìa, A R
- You have accessDisposition of ciprofloxacin in the isolated perfused rat liver.A R Abadìa, L De Francesco and A GuaitaniDrug Metabolism and Disposition February 1995, 23 (2) 197-200;
Andrews, P A
- You have accessEffect of intracellular chloride on the cellular pharmacodynamics of cis-diamminedichloroplatinum(II).M Jennerwein and P A AndrewsDrug Metabolism and Disposition February 1995, 23 (2) 178-184;
Arison, B H
- You have accessMetabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.S K Balani, B H Arison, L Mathai, L R Kauffman, R R Miller, R A Stearns, I W Chen and J H LinDrug Metabolism and Disposition February 1995, 23 (2) 266-270;
B
Balani, S K
- You have accessMetabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors.S K Balani, S M Pitzenberger, M S Schwartz, H G Ramjit and W J ThompsonDrug Metabolism and Disposition February 1995, 23 (2) 185-189;
- You have accessMetabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.S K Balani, B H Arison, L Mathai, L R Kauffman, R R Miller, R A Stearns, I W Chen and J H LinDrug Metabolism and Disposition February 1995, 23 (2) 266-270;
Benoit, E
- You have accessChiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes.P Moroni, T Buronfosse, C Longin-Sauvageon, P Delatour and E BenoitDrug Metabolism and Disposition February 1995, 23 (2) 160-165;
Burka, L T
- You have accessMetabolism and elimination of oxazepam in F344 rats.R J Griffin and L T BurkaDrug Metabolism and Disposition February 1995, 23 (2) 232-239;
Buronfosse, T
- You have accessChiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes.P Moroni, T Buronfosse, C Longin-Sauvageon, P Delatour and E BenoitDrug Metabolism and Disposition February 1995, 23 (2) 160-165;
C
Chakravarty, P K
- You have accessBiotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.R A Stearns, P K Chakravarty, R Chen and S H ChiuDrug Metabolism and Disposition February 1995, 23 (2) 207-215;
Chen, I W
- You have accessMetabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.S K Balani, B H Arison, L Mathai, L R Kauffman, R R Miller, R A Stearns, I W Chen and J H LinDrug Metabolism and Disposition February 1995, 23 (2) 266-270;
Chen, R
- You have accessBiotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.R A Stearns, P K Chakravarty, R Chen and S H ChiuDrug Metabolism and Disposition February 1995, 23 (2) 207-215;
Chenery, R J
- You have accessRole of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver.S E Clarke, A W Harrell and R J CheneryDrug Metabolism and Disposition February 1995, 23 (2) 251-254;
Cheraghali, A M
- You have accessPharmacokinetics and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-ethoxy-5,6-dihydro prodrugs in mice.A M Cheraghali, R Kumar, E E Knaus and L I WiebeDrug Metabolism and Disposition February 1995, 23 (2) 223-226;
Ching, M S
- You have accessFetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver.J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J MorganDrug Metabolism and Disposition February 1995, 23 (2) 190-196;
Chiu, S H
- You have accessBiotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.R A Stearns, P K Chakravarty, R Chen and S H ChiuDrug Metabolism and Disposition February 1995, 23 (2) 207-215;
Cho, A K
- You have accessInactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat.A Hiratsuka, T Y Chu, E W Distefano, L Y Lin, D A Schmitz and A K ChoDrug Metabolism and Disposition February 1995, 23 (2) 201-206;
Chu, T Y
- You have accessInactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat.A Hiratsuka, T Y Chu, E W Distefano, L Y Lin, D A Schmitz and A K ChoDrug Metabolism and Disposition February 1995, 23 (2) 201-206;
Clarke, S E
- You have accessRole of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver.S E Clarke, A W Harrell and R J CheneryDrug Metabolism and Disposition February 1995, 23 (2) 251-254;
D
De Francesco, L
- You have accessDisposition of ciprofloxacin in the isolated perfused rat liver.A R Abadìa, L De Francesco and A GuaitaniDrug Metabolism and Disposition February 1995, 23 (2) 197-200;
Delatour, P
- You have accessChiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes.P Moroni, T Buronfosse, C Longin-Sauvageon, P Delatour and E BenoitDrug Metabolism and Disposition February 1995, 23 (2) 160-165;
Distefano, E W
- You have accessInactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat.A Hiratsuka, T Y Chu, E W Distefano, L Y Lin, D A Schmitz and A K ChoDrug Metabolism and Disposition February 1995, 23 (2) 201-206;
Divakaruni, P
- You have accessComparison of acetyl coenzyme A:arylamine N-acetyltransferase activity in the liver, kidney, and intestine of male and female rats from three strains.J A Ware, P Divakaruni and C K SvenssonDrug Metabolism and Disposition February 1995, 23 (2) 295-297;
Du Souich, P
- You have accessContribution of the small intestine to the first-pass uptake and systemic clearance of propranolol in rabbits.P Du Souich, H Maurice and L HérouxDrug Metabolism and Disposition February 1995, 23 (2) 279-284;
E
el Mansouri, S
- You have accessTime- and dose-dependent kinetics of all-trans-retinoic acid in rats after oral or intravenous administration(s).S el Mansouri, M Tod, M Leclerq, O Petitjean, G Perret and M PorthaultDrug Metabolism and Disposition February 1995, 23 (2) 227-231;
G
Geerts, R J
- You have accessGastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog.L E Van Beijsterveldt, R J Geerts, K Wuyts, R J Woestenborghs, W E Meuldermans and J J HeykantsDrug Metabolism and Disposition February 1995, 23 (2) 216-222;
Ghabrial, H
- You have accessFetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver.J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J MorganDrug Metabolism and Disposition February 1995, 23 (2) 190-196;
Griffin, R J
- You have accessMetabolism and elimination of oxazepam in F344 rats.R J Griffin and L T BurkaDrug Metabolism and Disposition February 1995, 23 (2) 232-239;
Guaitani, A
- You have accessDisposition of ciprofloxacin in the isolated perfused rat liver.A R Abadìa, L De Francesco and A GuaitaniDrug Metabolism and Disposition February 1995, 23 (2) 197-200;
Guengerich, F P
- You have accessOxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174.C H Yun, H S Lee, H Lee, J K Rho, H G Jeong and F P GuengerichDrug Metabolism and Disposition February 1995, 23 (2) 285-289;
H
Harrell, A W
- You have accessRole of aldehyde oxidase in the in vitro conversion of famciclovir to penciclovir in human liver.S E Clarke, A W Harrell and R J CheneryDrug Metabolism and Disposition February 1995, 23 (2) 251-254;
Héroux, L
- You have accessContribution of the small intestine to the first-pass uptake and systemic clearance of propranolol in rabbits.P Du Souich, H Maurice and L HérouxDrug Metabolism and Disposition February 1995, 23 (2) 279-284;
Heykants, J J
- You have accessGastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog.L E Van Beijsterveldt, R J Geerts, K Wuyts, R J Woestenborghs, W E Meuldermans and J J HeykantsDrug Metabolism and Disposition February 1995, 23 (2) 216-222;
Hiratsuka, A
- You have accessInactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat.A Hiratsuka, T Y Chu, E W Distefano, L Y Lin, D A Schmitz and A K ChoDrug Metabolism and Disposition February 1995, 23 (2) 201-206;
J
Jamali, F
- You have accessInfluence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis.M Piquette-Miller and F JamaliDrug Metabolism and Disposition February 1995, 23 (2) 240-245;
Jennerwein, M
- You have accessEffect of intracellular chloride on the cellular pharmacodynamics of cis-diamminedichloroplatinum(II).M Jennerwein and P A AndrewsDrug Metabolism and Disposition February 1995, 23 (2) 178-184;
Jeong, H G
- You have accessOxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174.C H Yun, H S Lee, H Lee, J K Rho, H G Jeong and F P GuengerichDrug Metabolism and Disposition February 1995, 23 (2) 285-289;
K
Kauffman, L R
- You have accessMetabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.S K Balani, B H Arison, L Mathai, L R Kauffman, R R Miller, R A Stearns, I W Chen and J H LinDrug Metabolism and Disposition February 1995, 23 (2) 266-270;
Knaus, E E
- You have accessPharmacokinetics and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-ethoxy-5,6-dihydro prodrugs in mice.A M Cheraghali, R Kumar, E E Knaus and L I WiebeDrug Metabolism and Disposition February 1995, 23 (2) 223-226;
Kumar, R
- You have accessPharmacokinetics and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-ethoxy-5,6-dihydro prodrugs in mice.A M Cheraghali, R Kumar, E E Knaus and L I WiebeDrug Metabolism and Disposition February 1995, 23 (2) 223-226;
L
Laurenzana, E M
- You have accessAntipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6.E M Laurenzana, S L Sorrels and S M OwensDrug Metabolism and Disposition February 1995, 23 (2) 271-278;
Leclerq, M
- You have accessTime- and dose-dependent kinetics of all-trans-retinoic acid in rats after oral or intravenous administration(s).S el Mansouri, M Tod, M Leclerq, O Petitjean, G Perret and M PorthaultDrug Metabolism and Disposition February 1995, 23 (2) 227-231;
Lee, H
- You have accessOxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174.C H Yun, H S Lee, H Lee, J K Rho, H G Jeong and F P GuengerichDrug Metabolism and Disposition February 1995, 23 (2) 285-289;
Lee, H S
- You have accessOxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174.C H Yun, H S Lee, H Lee, J K Rho, H G Jeong and F P GuengerichDrug Metabolism and Disposition February 1995, 23 (2) 285-289;
Lin, J H
- You have accessMetabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.S K Balani, B H Arison, L Mathai, L R Kauffman, R R Miller, R A Stearns, I W Chen and J H LinDrug Metabolism and Disposition February 1995, 23 (2) 266-270;
Lin, L Y
- You have accessInactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat.A Hiratsuka, T Y Chu, E W Distefano, L Y Lin, D A Schmitz and A K ChoDrug Metabolism and Disposition February 1995, 23 (2) 201-206;
Liu, Z C
- You have accessOxidation of 5-aminosalicylic acid by hypochlorous acid to a reactive iminoquinone. Possible role in the treatment of inflammatory bowel diseases.Z C Liu, R A McClelland and J P UetrechtDrug Metabolism and Disposition February 1995, 23 (2) 246-250;
Longin-Sauvageon, C
- You have accessChiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes.P Moroni, T Buronfosse, C Longin-Sauvageon, P Delatour and E BenoitDrug Metabolism and Disposition February 1995, 23 (2) 160-165;
M
Mathai, L
- You have accessMetabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.S K Balani, B H Arison, L Mathai, L R Kauffman, R R Miller, R A Stearns, I W Chen and J H LinDrug Metabolism and Disposition February 1995, 23 (2) 266-270;
Matsunaga, T
- You have accessOxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.K Watanabe, T Matsunaga, I Yamamoto and H YashimuraDrug Metabolism and Disposition February 1995, 23 (2) 261-265;
Maurice, H
- You have accessContribution of the small intestine to the first-pass uptake and systemic clearance of propranolol in rabbits.P Du Souich, H Maurice and L HérouxDrug Metabolism and Disposition February 1995, 23 (2) 279-284;
McClelland, R A
- You have accessOxidation of 5-aminosalicylic acid by hypochlorous acid to a reactive iminoquinone. Possible role in the treatment of inflammatory bowel diseases.Z C Liu, R A McClelland and J P UetrechtDrug Metabolism and Disposition February 1995, 23 (2) 246-250;
Meuldermans, W E
- You have accessGastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog.L E Van Beijsterveldt, R J Geerts, K Wuyts, R J Woestenborghs, W E Meuldermans and J J HeykantsDrug Metabolism and Disposition February 1995, 23 (2) 216-222;
Miller, R R
- You have accessMetabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.S K Balani, B H Arison, L Mathai, L R Kauffman, R R Miller, R A Stearns, I W Chen and J H LinDrug Metabolism and Disposition February 1995, 23 (2) 266-270;
Morgan, D J
- You have accessFetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver.J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J MorganDrug Metabolism and Disposition February 1995, 23 (2) 190-196;
Moroni, P
- You have accessChiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes.P Moroni, T Buronfosse, C Longin-Sauvageon, P Delatour and E BenoitDrug Metabolism and Disposition February 1995, 23 (2) 160-165;
Mugford, C A
- You have accessContribution of oxidation and deacetylation to the bioactivation of acetaminophen in vitro in liver and kidney from male and female Sprague-Dawley rats.C A Mugford and J B TarloffDrug Metabolism and Disposition February 1995, 23 (2) 290-294;
O
Owens, S M
- You have accessAntipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6.E M Laurenzana, S L Sorrels and S M OwensDrug Metabolism and Disposition February 1995, 23 (2) 271-278;
P
Pang, K S
- You have accessKinetics of sequential metabolism. Contribution of parallel, primary metabolic pathways to the formation of a common, secondary metabolite.K S PangDrug Metabolism and Disposition February 1995, 23 (2) 166-177;
- You have accessBenzoic acid glycine conjugation in the isolated perfused rat kidney.K Poon and K S PangDrug Metabolism and Disposition February 1995, 23 (2) 255-260;
Perret, G
- You have accessTime- and dose-dependent kinetics of all-trans-retinoic acid in rats after oral or intravenous administration(s).S el Mansouri, M Tod, M Leclerq, O Petitjean, G Perret and M PorthaultDrug Metabolism and Disposition February 1995, 23 (2) 227-231;
Petitjean, O
- You have accessTime- and dose-dependent kinetics of all-trans-retinoic acid in rats after oral or intravenous administration(s).S el Mansouri, M Tod, M Leclerq, O Petitjean, G Perret and M PorthaultDrug Metabolism and Disposition February 1995, 23 (2) 227-231;
Piquette-Miller, M
- You have accessInfluence of severity of inflammation on the disposition kinetics of propranolol enantiomers in ketoprofen-treated and untreated adjuvant arthritis.M Piquette-Miller and F JamaliDrug Metabolism and Disposition February 1995, 23 (2) 240-245;
Pitzenberger, S M
- You have accessMetabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors.S K Balani, S M Pitzenberger, M S Schwartz, H G Ramjit and W J ThompsonDrug Metabolism and Disposition February 1995, 23 (2) 185-189;
Poon, K
- You have accessBenzoic acid glycine conjugation in the isolated perfused rat kidney.K Poon and K S PangDrug Metabolism and Disposition February 1995, 23 (2) 255-260;
Porthault, M
- You have accessTime- and dose-dependent kinetics of all-trans-retinoic acid in rats after oral or intravenous administration(s).S el Mansouri, M Tod, M Leclerq, O Petitjean, G Perret and M PorthaultDrug Metabolism and Disposition February 1995, 23 (2) 227-231;
R
Ramjit, H G
- You have accessMetabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors.S K Balani, S M Pitzenberger, M S Schwartz, H G Ramjit and W J ThompsonDrug Metabolism and Disposition February 1995, 23 (2) 185-189;
Rho, J K
- You have accessOxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174.C H Yun, H S Lee, H Lee, J K Rho, H G Jeong and F P GuengerichDrug Metabolism and Disposition February 1995, 23 (2) 285-289;
Ring, J A
- You have accessFetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver.J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J MorganDrug Metabolism and Disposition February 1995, 23 (2) 190-196;
S
Schmitz, D A
- You have accessInactivation of constitutive hepatic cytochromes P450 by phencyclidine in the rat.A Hiratsuka, T Y Chu, E W Distefano, L Y Lin, D A Schmitz and A K ChoDrug Metabolism and Disposition February 1995, 23 (2) 201-206;
Schwartz, M S
- You have accessMetabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors.S K Balani, S M Pitzenberger, M S Schwartz, H G Ramjit and W J ThompsonDrug Metabolism and Disposition February 1995, 23 (2) 185-189;
Shulkes, A
- You have accessFetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver.J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J MorganDrug Metabolism and Disposition February 1995, 23 (2) 190-196;
Smallwood, R A
- You have accessFetal hepatic propranolol metabolism. Studies in the isolated perfused fetal sheep liver.J A Ring, H Ghabrial, M S Ching, A Shulkes, R A Smallwood and D J MorganDrug Metabolism and Disposition February 1995, 23 (2) 190-196;
Sorrels, S L
- You have accessAntipeptide antibodies targeted against specific regions of rat CYP2D1 and human CYP2D6.E M Laurenzana, S L Sorrels and S M OwensDrug Metabolism and Disposition February 1995, 23 (2) 271-278;
Stearns, R A
- You have accessBiotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.R A Stearns, P K Chakravarty, R Chen and S H ChiuDrug Metabolism and Disposition February 1995, 23 (2) 207-215;
- You have accessMetabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine.S K Balani, B H Arison, L Mathai, L R Kauffman, R R Miller, R A Stearns, I W Chen and J H LinDrug Metabolism and Disposition February 1995, 23 (2) 266-270;
Svensson, C K
- You have accessComparison of acetyl coenzyme A:arylamine N-acetyltransferase activity in the liver, kidney, and intestine of male and female rats from three strains.J A Ware, P Divakaruni and C K SvenssonDrug Metabolism and Disposition February 1995, 23 (2) 295-297;
T
Tarloff, J B
- You have accessContribution of oxidation and deacetylation to the bioactivation of acetaminophen in vitro in liver and kidney from male and female Sprague-Dawley rats.C A Mugford and J B TarloffDrug Metabolism and Disposition February 1995, 23 (2) 290-294;
Thompson, W J
- You have accessMetabolism of L-689,502 by rat liver slices to potent HIV-1 protease inhibitors.S K Balani, S M Pitzenberger, M S Schwartz, H G Ramjit and W J ThompsonDrug Metabolism and Disposition February 1995, 23 (2) 185-189;
Tod, M
- You have accessTime- and dose-dependent kinetics of all-trans-retinoic acid in rats after oral or intravenous administration(s).S el Mansouri, M Tod, M Leclerq, O Petitjean, G Perret and M PorthaultDrug Metabolism and Disposition February 1995, 23 (2) 227-231;
U
Uetrecht, J P
- You have accessOxidation of 5-aminosalicylic acid by hypochlorous acid to a reactive iminoquinone. Possible role in the treatment of inflammatory bowel diseases.Z C Liu, R A McClelland and J P UetrechtDrug Metabolism and Disposition February 1995, 23 (2) 246-250;
V
Van Beijsterveldt, L E
- You have accessGastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog.L E Van Beijsterveldt, R J Geerts, K Wuyts, R J Woestenborghs, W E Meuldermans and J J HeykantsDrug Metabolism and Disposition February 1995, 23 (2) 216-222;
W
Ware, J A
- You have accessComparison of acetyl coenzyme A:arylamine N-acetyltransferase activity in the liver, kidney, and intestine of male and female rats from three strains.J A Ware, P Divakaruni and C K SvenssonDrug Metabolism and Disposition February 1995, 23 (2) 295-297;
Watanabe, K
- You have accessOxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.K Watanabe, T Matsunaga, I Yamamoto and H YashimuraDrug Metabolism and Disposition February 1995, 23 (2) 261-265;
Wiebe, L I
- You have accessPharmacokinetics and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-ethoxy-5,6-dihydro prodrugs in mice.A M Cheraghali, R Kumar, E E Knaus and L I WiebeDrug Metabolism and Disposition February 1995, 23 (2) 223-226;
Woestenborghs, R J
- You have accessGastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog.L E Van Beijsterveldt, R J Geerts, K Wuyts, R J Woestenborghs, W E Meuldermans and J J HeykantsDrug Metabolism and Disposition February 1995, 23 (2) 216-222;
Wuyts, K
- You have accessGastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog.L E Van Beijsterveldt, R J Geerts, K Wuyts, R J Woestenborghs, W E Meuldermans and J J HeykantsDrug Metabolism and Disposition February 1995, 23 (2) 216-222;
Y
Yamamoto, I
- You have accessOxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.K Watanabe, T Matsunaga, I Yamamoto and H YashimuraDrug Metabolism and Disposition February 1995, 23 (2) 261-265;
Yashimura, H
- You have accessOxidation of tolualdehydes to toluic acids catalyzed by cytochrome P450-dependent aldehyde oxygenase in the mouse liver.K Watanabe, T Matsunaga, I Yamamoto and H YashimuraDrug Metabolism and Disposition February 1995, 23 (2) 261-265;
Yeleswaram, K
- You have accessRelevance of tissue distribution studies.K YeleswaramDrug Metabolism and Disposition February 1995, 23 (2) 159;
Yun, C H
- You have accessOxidation of the angiotensin II receptor antagonist losartan (DuP 753) in human liver microsomes. Role of cytochrome P4503A(4) in formation of the active metabolite EXP3174.C H Yun, H S Lee, H Lee, J K Rho, H G Jeong and F P GuengerichDrug Metabolism and Disposition February 1995, 23 (2) 285-289;
In this issue

Advertisement